Over 451 million people across the globe suffer from diabetes. In 2016, over 5 million people died due to diabetes, and the WHO predicts diabetes will be the 7th leading cause of death by 2030. 

Navitas Life Sciences has the capabilities and resources to enable biosimilars companies to bring effective anti-diabetic therapies to the market quickly and safely.

© 2019 Navitas Life Sciences | Privacy Policy